Literature DB >> 16969655

[Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient].

C Voigt1, H Lill.   

Abstract

With the increasing occurrence of predisposing factors, invasive candidiasis is being diagnosed more frequently. Based on a review of only a few previous reported cases, we describe and discuss the unusual case of candidal cervical spondylodiscitis in a 36 year old man who had sustained a polytrauma, complicated through a Candida albicans pneumonia. The main symptom was disabling neck pain. Clinical, laboratory and radiological findings were unspecific. The definitive diagnosis was determined by MRI imaging and biopsy. The early diagnosis and surgical treatment with a sufficient debridement and stabilisation of the affected segment combined with a prolonged antifungal therapy lead to good results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969655     DOI: 10.1007/s00113-006-1143-0

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  17 in total

Review 1.  The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapy.

Authors:  R E Lewis; M E Klepser
Journal:  Am J Health Syst Pharm       Date:  1999-03-15       Impact factor: 2.637

2.  The vascular anatomy of the spine and its relationship to pyogenic vertebral osteomyelitis.

Authors:  A M WILEY; J TRUETA
Journal:  J Bone Joint Surg Br       Date:  1959-11

3.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Authors:  J H Rex; T J Walsh; J D Sobel; S G Filler; P G Pappas; W E Dismukes; J E Edwards
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

Review 4.  Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.

Authors:  E J Anaissie; R O Darouiche; D Abi-Said; O Uzun; J Mera; L O Gentry; T Williams; D P Kontoyiannis; C L Karl; G P Bodey
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

Review 5.  Candidal vertebral osteomyelitis: report of 6 patients, and a review.

Authors:  L Hendrickx; E Van Wijngaerden; I Samson; W E Peetermans
Journal:  Clin Infect Dis       Date:  2001-02-06       Impact factor: 9.079

Review 6.  Candida vertebral osteomyelitis: a case report and review of the literature.

Authors:  Y C Wang; S T Lee
Journal:  Chang Gung Med J       Date:  2001-12

7.  Diagnosis and treatment of Candida vertebral osteomyelitis: clinical experience with a short course therapy of amphotericin B lipid complex.

Authors:  Lawrence A Cone; Richard G Byrd; Barbara E Potts; Moxell Wuesthoff
Journal:  Surg Neurol       Date:  2004-09

Review 8.  Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature.

Authors:  C Hennequin; P Bourée; C Hiesse; B Dupont; B Charpentier
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

Review 9.  Candida albicans osteomyelitis: case report and literature review.

Authors:  Félix Arias; Sofía Mata-Essayag; María E Landaeta; Claudia Hartung de Capriles; Celina Pérez; María J Núñez; Ana Carvajal; Marisela Silva
Journal:  Int J Infect Dis       Date:  2004-09       Impact factor: 3.623

10.  A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.

Authors:  J H Rex; J E Bennett; A M Sugar; P G Pappas; C M van der Horst; J E Edwards; R G Washburn; W M Scheld; A W Karchmer; A P Dine
Journal:  N Engl J Med       Date:  1994-11-17       Impact factor: 91.245

View more
  1 in total

Review 1.  Management of destructive Candida albicans spondylodiscitis of the cervical spine: a systematic analysis of literature illustrated by an unusual case.

Authors:  Josef Stolberg-Stolberg; Dagmar Horn; Steffen Roßlenbroich; Oliver Riesenbeck; Stefanie Kampmeier; Michael Mohr; Michael J Raschke; René Hartensuer
Journal:  Eur Spine J       Date:  2016-11-05       Impact factor: 3.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.